Abstract
This research service explores the market for therapeutics that are developed for the treatment of Fibromyalgia Syndrome in Europe. It analyses the various challenges faced by the pharmaceutical companies and the competitive advantage of their products in the market.
Table of Contents
1 RESEARCH METHODOLOGY
- Research Objective and Scope
- Methodology
2 MARKET OVERVIEW
- Introduction
- Disease Characteristics
- Epidimeology
- Market Definition and Segmentation
- Definition
- Segmentation
3 INDUSTRY CHALLENGES
- Key Challenges
- Challenges Faced by the Niche CNS Disorders Markets
4 TOTAL EUROPEAN MARKETS FOR FIBROMYALGIA SYNDROME
- Overview and Definitions
- Market Drivers
- Market Restraints
- Explored Treatment Options
- Unmet Needs
- Market Engineering Measurements
- Competitive Analysis
- Pfizer
- Eli Lilly
- Forest/Cypress Bioscience
5 TOTAL FORECASTS FOR THE EUROPEAN MARKETS FOR FIBROMYALGIA SYNDROME
- Patient and Revenue Forecasts
- Patient Population
- Revenue Forecasts
6 STRATEGIC RECOMMENDATIONS
- Recommendations for the European Markets for Fibromyalgia Syndrome.
- Recommendations
7 DATABASE OF KEY INDUSTRY PARTICIPANTS
- Key Market Participants
- Companies in the Fibromyalgia Syndrome Market
8 DECISION SUPPORT DATABASES
- Databases for Analysis
- Total Cases of Stroke
- Deaths due to Stroke
- Total Cases of Epilepsy
- Total Cases of Multiple Sclerosis
- Deaths due to Epilepsy
- Deaths due to Multiple Sclerosis
